Synopsys (NASDAQ:SNPS) Price Target Raised to $574.00

by · The Markets Daily

Synopsys (NASDAQ:SNPS – Free Report) had its target price hoisted by Morgan Stanley from $500.00 to $574.00 in a research report released on Tuesday morning,Benzinga reports. They currently have an overweight rating on the semiconductor company’s stock.

A number of other brokerages also recently weighed in on SNPS. HSBC downgraded Synopsys from a “buy” rating to a “reduce” rating in a research note on Friday, September 25th. Benchmark reaffirmed a “buy” rating and set a $570.00 price target on shares of Synopsys in a research report on Thursday, August 27th. Barclays started coverage on Synopsys in a report on Friday, September 25th. They set an “overweight” rating on the stock. Weiss Ratings lowered Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, September 11th. Finally, JPMorgan Chase & Co. cut their price objective on Synopsys from $650.00 to $600.00 in a research report on Thursday, August 27th. One analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Synopsys currently has an average rating of “Moderate Buy” and a consensus target price of $575.00.

Read Our Latest Stock Analysis on Synopsys

Synopsys Stock Performance

NASDAQ SNPS opened at $422.48 on Tuesday. The company has a fifty day moving average price of $430.15 and a 200-day moving average price of $443.27. The firm has a market cap of $80.96 billion, a price-to-earnings ratio of 45.85, a PEG ratio of 1.84 and a beta of 1.21. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. Synopsys has a 1 year low of $362.55 and a 1 year high of $539.48.

Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The company had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. During the same period last year, the firm earned $3.39 earnings per share. The firm’s revenue was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, equities research analysts predict that Synopsys will post 11.00 EPS for the current fiscal year.

Synopsys declared that its board has authorized a share buyback plan on Monday, October 5th that authorizes the company to buy back $1.00 billion in shares. This repurchase authorization authorizes the semiconductor company to buy up to 1.1% of its shares through open market purchases. Stock repurchase plans are typically a sign that the company’s management believes its shares are undervalued.

Insider Activity at Synopsys

In related news, CFO Sudhindra Kankanwadi sold 9,170 shares of Synopsys stock in a transaction that occurred on Tuesday, October 6th. The shares were sold at an average price of $500.00, for a total value of $4,585,000.00. Following the sale, the chief financial officer owned 22,717 shares of the company’s stock, valued at approximately $11,358,500. The trade was a 28.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Aart de Geus sold 25,000 shares of the company’s stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $441.76, for a total value of $11,044,000.00. Following the completion of the transaction, the insider owned 120,421 shares in the company, valued at approximately $53,197,180.96. The trade was a 17.19% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 117,163 shares of company stock valued at $51,366,457 over the last quarter. 0.56% of the stock is currently owned by insiders.

Institutional Trading of Synopsys

Several hedge funds have recently made changes to their positions in the company. Elevation Wealth Partners LLC grew its stake in shares of Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after acquiring an additional 27 shares during the period. Osbon Capital Management LLC purchased a new stake in Synopsys in the 2nd quarter worth about $25,000. IMG Wealth Management Inc. purchased a new stake in Synopsys in the 2nd quarter worth about $28,000. GK Wealth Management LLC bought a new stake in Synopsys in the 3rd quarter valued at about $28,000. Finally, Geneos Wealth Management Inc. raised its stake in Synopsys by 151.5% in the 1st quarter. Geneos Wealth Management Inc. now owns 83 shares of the semiconductor company’s stock valued at $33,000 after acquiring an additional 50 shares during the period. 85.47% of the stock is currently owned by institutional investors.

About Synopsys

(Get Free Report)

Synopsys, Inc is an electronic design automation (EDA) and semiconductor intellectual property company serving the global semiconductor and electronics industries. Its software helps engineers design, verify, test and manufacture advanced integrated circuits and electronic systems.

The company’s products and services support digital and analog design, functional verification, design-for-test, manufacturing and semiconductor engineering workflows. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, security solutions and other components used in system-on-chip designs.

In addition to its semiconductor design offerings, Synopsys provides software development and application security tools intended to help organizations identify and manage vulnerabilities and risks across the software development lifecycle.

Further Reading